Your browser doesn't support javascript.
loading
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.
Silvestri, Giovannino; Trotta, Rossana; Stramucci, Lorenzo; Ellis, Justin J; Harb, Jason G; Neviani, Paolo; Wang, Shuzhen; Eisfeld, Ann-Kathrin; Walker, Christopher J; Zhang, Bin; Srutova, Klara; Gambacorti-Passerini, Carlo; Pineda, Gabriel; Jamieson, Catriona H M; Stagno, Fabio; Vigneri, Paolo; Nteliopoulos, Georgios; May, Philippa C; Reid, Alistair G; Garzon, Ramiro; Roy, Denis-Claude; Moutuou, Moutuaata M; Guimond, Martin; Hokland, Peter; Deininger, Michael W; Fitzgerald, Garrett; Harman, Christopher; Dazzi, Francesco; Milojkovic, Dragana; Apperley, Jane F; Marcucci, Guido; Qi, Jianfei; Polakova, Katerina Machova; Zou, Ying; Fan, Xiaoxuan; Baer, Maria R; Calabretta, Bruno; Perrotti, Danilo.
Afiliación
  • Silvestri G; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Trotta R; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Stramucci L; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Ellis JJ; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Harb JG; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Neviani P; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Wang S; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Eisfeld AK; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Walker CJ; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Zhang B; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Srutova K; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Gambacorti-Passerini C; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Pineda G; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Jamieson CHM; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Stagno F; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Vigneri P; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Nteliopoulos G; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • May PC; Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, California.
  • Reid AG; Institute of Hematology and Blood Transfusion, University of Prague, Prague, Czech Republic.
  • Garzon R; Hematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy.
  • Roy DC; Department of Health Sciences, School of Health and Human Services, National University, San Diego, California.
  • Moutuou MM; Department of Medicine and Moores Cancer Center, University of California, San Diego, La Jolla, California.
  • Guimond M; Division of Hematology and Unit of Medical Oncology, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy.
  • Hokland P; Division of Hematology and Unit of Medical Oncology, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy.
  • Deininger MW; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Fitzgerald G; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Harman C; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Dazzi F; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Milojkovic D; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Apperley JF; Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada.
  • Marcucci G; Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada.
  • Qi J; Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada.
  • Polakova KM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Zou Y; Division of Hematology and Hematologic Malignancies and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Fan X; Center for Advanced Fetal Care University, University of Maryland School of Medicine, Baltimore, Maryland.
  • Baer MR; Center for Advanced Fetal Care University, University of Maryland School of Medicine, Baltimore, Maryland.
  • Calabretta B; Division of Cancer Studies, Rayne Institute, King's College London, London, United Kingdom.
  • Perrotti D; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Blood Cancer Discov ; 1(1): 48-67, 2020 07.
Article en En | MEDLINE | ID: mdl-32974613
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / MicroARNs Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / MicroARNs Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2020 Tipo del documento: Article